Company Overview of Natraceutical SA
Natraceutical SA develops and manufactures pharmaceutical products for customers in Europe. The company’s structure includes four divisions: Industrial Services Division; Pharma Division; R&D and Regulatory Division; and Biotech Division. The Industrial Services Division provides manufacturing services and out-licensing dossiers of specialized products, such as sterile products for injection, freeze-dried products, and penicillin/cephalosporin antibiotics, as well as topical formulations. The Pharma Division offers products in the fields of dermatology, women's care, respiratory, anti-infectious, pediatrics, and retail consumer healthcare products. The R&D and Regulatory Division engages in ...
Avenue Alcalde Barnils
Edif. A, 1º 3ª
Street Cugat del Vallés
Founded in 1929
Key Executives for Natraceutical SA
Natraceutical SA does not have any Key Executives recorded.
Natraceutical SA Key Developments
Reig Jofre Group Wins GBP 230 Million Multiple Awardees Contract for Supplying Generic Pharmaceuticals
May 27 15
Reig Jofre Group won a GBP 230 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part
of the Department of Health) for the supply of generic pharmaceuticals.
Reig Jofre Announces Earnings Results for the First Quarter of 2015
May 7 15
Reig Jofre announced earnings results for the first quarter of 2015. For the quarter, the company reported net profit of EUR 5.3 million (USD 6 million) in the first quarter, 41.1% more than in the same period of 2014. The company achieved sales of EUR 43 million, representing an increase of 5.3% compared to EUR 41 million in same period last year. The positive performance has been driven by development and manufacturing for third parties and the company's own research and development. At the end of March, net financial debt stood at EUR 17.7 million. The 5.3% sales increase fulfils company’s expectations after merging with Natraceutical. The company has stated that the first quarter has been one of ‘strong seasonality’ on pharmacy sales of nutritional supplements for weight control. Therefore, the first-quarter results cannot be extrapolated linearly to the rest of the year.
Natraceutical SA to Report Q1, 2015 Results on May 05, 2015
May 4 15
Natraceutical SA announced that they will report Q1, 2015 results on May 05, 2015
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries